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A B S T R A C T
Background: Rotational atherectomy with new ablative strategies have been proposed for the treatment 
of extremely calcified lesions prior to stent implantation. Nevertheless, few data are available about the 
adoption of these new strategies in contemporary practice and about late outcomes of patients undergoing 
this therapy. 
Methods: From July 2012 to November 2014, a retrospective single center registry was conducted, including 
all patients undergoing rotational atherectomy as part of the treatment of coronary arteries with heavy 
calcification or previous failed dilation. We evaluated technical aspects of atherectomy and late outcomes 
of patients for the occurrence of major adverse cardiovascular events (MACE), defined as death, Q-wave 
myocardial infarction or repeat target vessel revascularization. 
Results: Twenty-nine patients with a mean age of 69.5 ± 7.6 years, underwent atherectomy. The average 
burr-to-artery ratio was 0.54 ± 0.07, the initial rotational speed was 161.000 ± 13.928 and the rate of cutting 
balloon utilization after atherectomy was 45.1%. Angiographic success was achieved in all procedures. 
The median follow-up time was 13.2 months (IQ: 4.0-17.4) and there were three events: 1 death of non-
cardiac cause and 2 new target vessel revascularizations. The mean MACE-free survival time was 29.7 ± 
2.1 months. 
Conclusions: Contemporary rotational atherectomy incorporates less aggressive strategies of ablation with 
high rates of acute success and low occurrence of major adverse cardiovascular events during late follow-up.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Aterectomia rotacional em artérias com calcificação extrema ou falha  
em dilatação prévia: aspectos técnicos e evolução tardia após intervenção 
coronária percutânea
R E S U M O
Introdução: A aterectomia rotacional com incorporação de novas estratégias ablativas tem sido proposta 
para o preparo de lesões extremamente calcificadas. Entretanto, pouco se conhece a respeito da adoção 
dessas novas estratégias na prática contemporânea e sobre a evolução tardia dos pacientes submetidos a 
esse tratamento. Objetivamos avaliar os aspectos técnicos da aterectomia e a evolução tardia dos pacientes 
quanto à ocorrência de eventos cardiovasculares adversos maiores (ECAM).
Métodos: Estudo retrospectivo e unicêntrico, incluindo todos os pacientes submetidos à aterectomia 
rotacional como parte do tratamento de lesões coronárias com calcificação extrema ou falha de dilatação 
em procedimento prévio, no período de julho de 2012 a novembro de 2014. Foram definidos como ECAM: 
óbito, infarto agudo do miocárdio com onda Q e nova revascularização do vaso-alvo.
Resultados: Foram submetidos à aterectomia 29 pacientes com idade média de 69,5 ± 7,6 anos. A média 
da relação oliva/vaso foi de 0,54 ± 0,07; a velocidade de rotação inicial adotada foi de 161.000 ± 13.928 
e a taxa de utilização de cutting balloon pós-aterectomia foi de 45,1%. Sucesso angiográfico foi obtido 
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Introduction
Coronary rotational atherectomy (RA), at the time of its introduc-
tion, in 1988,1 became popular as an alternative mechanical ablative 
approach to conventional balloon angioplasty, differentiating itself 
by obtaining luminal gain, through reduction of the atherosclerotic 
plaque content.2,3 However, the greater technical complexity and the 
relatively high incidence of early and late complications in patients 
treated exclusively with this method determined the decline of its 
use in the following decade, especially after coronary stents became 
available.4
Over the past years, there has been a progressive increase in 
the number of patients and of highly complex lesions considered 
for percutaneous treatment. Due to this fact, anatomical chal-
lenging scenarios became frequent, such as marked coronary cal-
cification, which is associated with difficulty in crossing and 
dilating the lesions, and has a negative impact on the intervention 
outcome.5,6
In this context, RA started to be used again as an adjunct tool for 
percutaneous coronary intervention. Instead of the more aggressive 
strategy employed in the past, the present proposal includes 
smaller-caliber burrs and lower rotational velocity, for a geometric 
modification of the atherosclerotic plaque, followed by lesion dila-
tion with balloons and other devices that, together, allow for stent 
implantation with adequate expansion of its struts.7,8
There are few data on the use of these new strategies in contem-
porary practice and on the late evolution of patients undergoing this 
treatment. Therefore, this study aimed to evaluate the technical as-
pects of atherectomy and the late evolution of patients regarding the 
occurrence of major adverse cardiovascular events (MACE).
Methods
Study design and population
A retrospective study was performed in a single center dedicated 
to the treatment of high-complexity cardiac diseases. From July 
2012 to November 2014, this study included all patients undergoing 
RA as part of the treatment of coronary lesions with extreme calcifi-
cation (visible calcification in the fluoroscopic image before contrast 
injection) or previous failed dilation. Patients with restenotic lesions 
or with coronary artery bypass grafts were excluded.
Procedure and dual antiplatelet therapy
Patients received, prior to the intervention, dual antiplatelet 
therapy with a loading dose of 200 mg acetylsalicylic acid and 
600 mg clopidogrel. During the procedure, unfractionated heparin 
was used at the dose of 70 to 100 U/kg, and the use of IIb/IIIa glyco-
protein inhibitors was left at the operators' discretion.
All procedures were performed with the Rotablator RA system 
(Boston Scientific, Natick, USA), using only the transfemoral access 
route. The choice of burr size was carried out, considering the distal 
reference diameter of the target vessel, as assessed by angiography. 
Burr size was selected to attain a burr-to-artery ratio of 0.5 (maxi-
mum 0.7). The device velocity ranged between 140,000 and 180,000 
rpm. The atherectomy was interrupted, after a variable number of 
passages through the lesion or after the occurrence of complica-
tions.
The decision about device type and sizes used after ablation was 
left to the operators' discretion. After discharge, the recommended 
daily maintenance dose was 100 mg acetylsalicylic acid and 75 mg 
clopidogrel, with thienopyridine withdrawal, according to the at-
tending physician’s discretion.
Outcomes and definitions
The primary outcome was the occurrence of MACE, defined as 
death, Q-wave acute myocardial infarction (AMI), and target-vessel 
revascularization in the late follow-up, verified by the institutional 
electronic medical record and by telephone contact. Secondarily, 
patients’ hospital outcomes were evaluated regarding the occur-
rence of death, stroke, periprocedural infarction (type 4a infarc-
tion), target vessel revascularization, and contrast-induced 
nephropathy.
Angiographic success was defined as residual stenosis < 50% and 
Thrombolysis in Myocardial Infarction 3 (TIMI) coronary flow. Peri-
procedural infarction was defined as clinical, electrocardiographic, 
or echocardiographic evidence of ischemia accompanied by an in-
crease of more than five times the 99th percentile of creatine kinase-
MB (CK-MB) mass or troponin I values in patients with normal 
baseline values, or new increase > 20% after stability or early drop, in 
patients with baseline values higher than the 99th percentile of the 
method. Q-wave AMI was defined as the appearance of new patho-
logical Q waves in the electrocardiogram, with or without symp-
toms of  ischemia or abnor mal myoc ardia l  cont rac t i l it y. 
Contrast-induced nephropathy was defined as serum creatinine in-
crease higher than 25% compared to baseline or greater than 0.5 mg/
dL in absolute terms, without other apparent cause after contrast 
medium administration.
Statistical analysis
The analysis of clinical and angiographic data was performed 
using SPSS (IBM Corp., New York, USA). Continuous variables were 
described as means and standard deviations, and categorical vari-
ables as absolute numbers and percentages. For time of follow-up, 
median and interquartile ranges (25th-75th percentiles) were used. 
Survival analysis was performed using the Kaplan-Meier method.
Results
During the analyzed period, 29 patients met the inclusion criteria 
and were evaluated in this study. The mean age of the population 
was 69.5 ± 7.6 years, and there was a high percentage of diabetes 
mellitus (62.1%) and multivessel pattern (79.3%) (Table 1).
A total of 29 procedures were performed, with 31 lesions treated 
with the Rotablator. The initial burr diameter was 1.54 ± 0.22 mm, 
em todos os procedimentos. Na evolução tardia, a mediana de tempo de seguimento foi de 13,2 meses 
(intervalo interquartil: 4,0 a 17,4 meses). Foram registrados um óbito por causa não cardíaca e duas novas 
revascularizações do vaso-alvo. A média do tempo de sobrevivência livre de ECAM foi de 29,7 ± 2,1 meses.
Conclusões: A aterectomia rotacional contemporânea incorporou estratégias menos agressivas de ablação, 
com elevada taxa de sucesso imediato e baixa ocorrência de ECAM na evolução tardia.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
40 P. H. M. C. Melo et al. / Rev Bras Cardiol Invasiva. 2015;23(1):38-41
with burr-to-artery ratio of 0.54 ± 0.07, and initial rotational speed 
of 161,000 ± 13,928 rpm. In 93.6% of the interventions, balloon dila-
tion of the lesion was performed after RA, using a cutting balloon in 
45.1% of cases. Drug-eluting stents were used in 77.4% of patients, 
with a mean of 1.54 ± 0.66 stents per lesion and mean length of im-
planted stents of 40.3 ± 20.0 mm (Table 2).
Angiographic success was achieved in 100% of the procedures. 
Complications associated with atherectomy are shown in Table 3. 
The periprocedural infarction rate (type 4a) was 10.3%, with no 
deaths, stroke, or new target-vessel revascularization during in-
hospital follow-up (Table 4).
The late follow-up (Table 4) showed two new target-vessel revas-
cularizations and one death from non-cardiac cause (septic shock 6 
months after the intervention). The mean MACE-free survival time 
was 29.7 ± 2.1 months (Fig. 1).
Discussion
The results of the present study suggest that RA, as an adjunctive 
technique for percutaneous treatment of lesions with extreme calci-
fication, is safe and effective, with high procedural success rate and 
favorable evolution in the late follow-up. This registry highlighted 
the clinical complexity of the population – especially the high per-
centage of diabetes mellitus (62.1%), chronic renal failure (24.1%), 
multivessel pattern (79.3%), and previous CABG (31.0%). The 
atherectomy technique used was characterized by conservative 
burr-to-artery ratio, initial burr rotation velocity < 180,000 rpm, low 
total ablation time, and high percentage of additional dilation of le-
sions with significant use of cutting balloon.
Conservative burr-to-artery ratio (< 0.7) has been suggested in 
the context of RA as a tool to modify plaque compliance, associated 
to high angiographic success rate and lower incidence of complica-
tions, such as coronary perforation and dissection.9 The burr rota-
Table 1
Clinical and angiographic characteristics.
Variable n = 29 patients/31 lesions
Age, years 69.5 ± 7.6
Male gender, n (%) 21 (72.4)
Hypertension, n (%) 27 (93.1)
Diabetes mellitus, n (%) 18 (62.1)
Dyslipidemia, n (%) 28 (96.6)
Renal failure* n (%) 7 (24.1)
Heart failure, n (%) 8 (27.6)
Previous CABG, n (%) 5 (17.2)
Previous coronary angioplasty, n (%) 4 (13.8)
Previous acute myocardial infarction, n (%) 4 (13.8)
Previous stroke, n (%) 1 (3.5)
Smoking, n (%) 13 (44.8)
Current 3 (10.3)
Previous 10 (34.5)
Clinical picture, n (%)
Stable angina or anginal equivalent 19 (65.5)
Acute coronary syndrome 10 (34.5)
Presence of ischemia in noninvasive test 8 (27.6)
Health care provider, n (%)
Brazilian Unified Health System 17 (58.6)
Supplemental Health System 12 (41.4)
Arterial pattern, n (%)
One-vessel 6 (20.7)
Two-vessel 6 (20.7)
Three-vessel 17 (58.6)
Target vessel, n (%)
Left main coronary artery 2 (6.5)
Left anterior descending artery 19 (61.3)
Left circumflex artery 4 (12.9)
Right coronary artery 6 (19.4)
Angiographic classification of lesions, n (%)
Type A 0
Type B1 0
Type B2 1 (3.2)
Type C 30 (96.8)
Bifurcation lesion, n (%) 10 (32.2)
Target-vessel coronary flow (TIMI), n (%)
TIMI 0 0
TIMI 1 1 (3.2)
TIMI 2 5 (16.1)
TIMI 3 25 (80.6)
Degree of target-lesion stenosis, % 87 ± 9
CABG: coronary artery bypass grafting; TIMI: Thrombolysis in Myocardial Infarction.
* Calculated creatinine clearance < 60 mL/min.
Table 2
Technical aspects of procedure.
Variable n = 29 patients/31 lesions
Indication of atherectomy, n (%)
Failure to dilate the lesion in a previous procedure 6 (19.4)
Extensive angiographic calcification 25 (80.6)
Burr initial diameter, mm 1.54 ± 0.22
Use of second burr of larger diameter, n (%) 4 (12.9)
Burr/vessel distal reference ratio 0.54 ± 0.07
Number of passages through lesion with burr 3.15 ± 2.01
Total rotation time, seconds 65 ± 45
Initial rotational velocity, rpm 161,000 ± 13,928
Rotation increase during atherectomy, n (%) 5 (16,1)
Radiation dose, DAP 234,400 ± 141,458
Radiation dose, Kerma 3,839.12 ± 2,404.83
Contrast volume, mL 260 ± 149
Vascular access, n (%)
Radial 0 (0)
Femoral 29 (100)
Arterial sheath, n (%)
6 F 5 (17.2)
7 F 22 (75.9)
8 F 2 (6.9)
Ad hoc procedure, n (%) 6 (20.7)
Procedures guided by IVUS, n (%) 6 (20.7)
Lesion pre-dilation after atherectomy, n (%) 29 (93.6)
Use of cutting balloon, n (%) 14 (45.1)
Number of treated vessels by procedure 1.35 ± 0.48
Use of drug-eluting stents, n (%) 24 (77.4)
Number of stents in the target-vessel 1.54 ± 0.66
Length of stents in the target-vessel, mm 40.3 ± 20.0
Prophylactic pacemaker, n (%) 2 (6.9)
Intra-aortic balloon, n (%) 0
DAP: dose-area product; IVUS: intravascular ultrasound; RPM: revolutions per minute.
Table 3
Results of the procedure and hospital outcomes.
Variable n = 29 patients/31 lesions
Angiographic success, n (%) 31 (100.0)
Vascular complications related to the procedure, n (%)
Slow flow 2 (6.5)
No reflow 1 (3.2)
Coronary dissection 3 (9.7)
Coronary perforation 1 (3.2)
Death, n (%) 0 (0)
Stroke, n (%) 0 (0)
Periprocedural AMI (type 4a), n (%) 3 (10.3)
Target-vessel revascularization, n (%) 0 (0)
Contrast-induced nephropathy, n (%) 0 (0)
Hospitalization time, days 6 (3-9)
AMI: acute myocardial infarction.
Table 4
Late evolution.
Variable n = 29 patients
MACE, n (%) 3 (10.3)
Death from all causes, n (%) 1 (3.4)
Cardiac death 0 (0)
Q-wave AMI, n (%) 0 (0)
Target-vessel revascularization, n (%) 2 (6.9)
MACE: major adverse cardiovascular events; AMI: acute myocardial infarction.
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tion velocity, in turn, also appears to influence procedure outcome, 
as velocities > 180,000 rpm have been related to the risk of athero-
sclerotic debris embolization and elevation of myocardial necrosis 
markers.10 In spite of these strategies to increase atherectomy safety, 
recent registries have shown complications rates that are still higher 
than those observed in other percutaneous coronary interven-
tions.11,12
This series assessed the combined use of the strategies described 
above, resulting in a single case of perforation, which occurred in an 
angled left circumflex artery, with a rate of coronary dissection of 
9.7%, all percutaneously resolved with stent implantation.
Another characteristic of contemporary ablative strategy is the 
need for additional plaque preparation prior to stent implantation, 
due to the smaller luminal gain obtained by using burrs of smaller 
diameter. The use of a cutting balloon in this context is associated 
with higher minimum in-stent sectional area, despite the late higher 
luminal loss.13 In the present study, a 93.6% rate of additional dilation 
after atherectomy was found, using a cutting balloon in 45.1% of pro-
cedures, resulting in immediate angiographic success in all cases, 
with low incidence of new target-vessel revascularization in the late 
follow-up.
The retrospective design and the relatively low number of pa-
tients were limitations of this study; however, this was a selected 
population, of high complexity, in which it was possible to describe 
the technical aspects of the procedure and perform late clinical 
follow-up.
Conclusions
Contemporary rotational atherectomy with the incorporation of 
conservative ablation strategies demonstrated safety and efficacy in 
the percutaneous treatment of calcified lesions in high-complexity 
patients.
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Figura 1. Kaplan-Meier curve for MACE-free survival. MACE, major adverse cardiovas-
cular events.
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